"Medical Health" is a term often used to refer broadly to the overall state of health within the context of medicine and healthcare. It encompasses various aspects of well-being, disease prevention, diagnosis, treatment, and overall healthcare management. The pharmaceutical industry stands at the forefront of medical innovation, driving the development of life-saving medications. However, inherent challenges such as drug pricing, market competition, and the ethics of marketing practices cast a shadow on its contributions. The tension between profit motives and public health objectives necessitates a delicate balancing act. Regulatory reforms, international collaboration, and a commitment to ethical business practices are pivotal for ensuring that pharmaceutical advancements align with the overarching goal of improving global health.
Ethical considerations within the pharmaceutical industry extend to issues such as clinical trial transparency, patient access to experimental treatments, and the impact of intellectual property rights on drug affordability. Emphasizing transparency, promoting fair pricing models, and fostering partnerships between industry players and public health entities contribute to building a pharmaceutical sector that is both economically viable and ethically responsible.







Title : Using collaborative civil discourse to address AI issues
Nina Beaman, Mary Baldwin University, United States
Title : Managing comprehensive communication and cooperation in intelligent and ethical personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany